Skip Ribbon Commands
Skip to main content
Menu

Sentinel Lymph Node Biopsy (SLNB)

Sentinel Lymph Node Biopsy (SLNB) is recommended for early-stage breast cancer when the lymph nodes in the armpit do not appear to have cancer.

Sentinel lymph nodes (SLN) are the first few lymph nodes in the armpit where the lymphatic vessels from the breast drain to. These will be removed during surgery and examined under the microscope (frozen section) to determine if cancer has spread to the SLN.

This is done under general anaesthesia (GA). A blue dye or a radioactive substance is injected around the cancer site or at the nipple prior to surgery to locate the SLN. The radioactive substance will be injected before the operation. The blue dye will be injected during the operation.

In general, if cancer is detected in the SLN, lymph nodes in the axilla will be removed. If no cancer is detected in the SLN, no further surgery is needed.

The final histology (microscopic assessment) will be reviewed about 2 weeks after surgery. In up to 5 percent of cases, the final assessment of the SLN may be different from the initial frozen section result and a second operation may be recommended.

If the dye or radioactive substance is not able to identify the SLN, removal of all the lymph nodes (axillary clearance) will be done.

Sentinel lymph node biopsy is used to examine the lymph nodes for cancer.

Sentinel lymph node biopsy is used to examine the lymph nodes for cancer.

Sentinel lymph node biopsy is used to examine the lymph nodes for cancer.

caption Sentinel lymph node biopsy is used to examine the lymph nodes for cancer.

Condition treated at: